Astria Therapeutics Inc. has announced new compensation terms under its 2022 Inducement Stock Incentive Plan. On August 1, 2025, the company granted stock options to purchase 180,000 shares of its common stock as part of an inducement for two new employees. These options, set at an exercise price of $6.56 per share, equal to the stock's closing price on the grant date, will vest over four years. The vesting schedule includes 25% of the shares vesting on the first anniversary of the employees' start date, with the remaining shares vesting monthly over the subsequent 36 months, contingent on their ongoing employment with Astria.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。